0001760319-19-000030.txt : 20191118 0001760319-19-000030.hdr.sgml : 20191118 20191118164111 ACCESSION NUMBER: 0001760319-19-000030 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191118 ITEM INFORMATION: Completion of Acquisition or Disposition of Assets FILED AS OF DATE: 20191118 DATE AS OF CHANGE: 20191118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KID CASTLE EDUCATIONAL CORP CENTRAL INDEX KEY: 0001049011 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-PROFESSIONAL & COMMERCIAL EQUIPMENT & SUPPLIES [5040] IRS NUMBER: 592549529 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-39629 FILM NUMBER: 191228024 BUSINESS ADDRESS: STREET 1: 7TH FLOOR STREET 2: 127-1 SUNG CHIANG ROAD CITY: TAIPEI, TAIWAN ROC STATE: F5 ZIP: 00000 BUSINESS PHONE: 011886225061688 MAIL ADDRESS: STREET 1: 7TH FLOOR STREET 2: 127-1 SUNG CHIANG ROAD CITY: TAIPEI, TAIWAN ROC STATE: F5 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: KING BALL INTERNATIONAL TECHNOLOGY CORP DATE OF NAME CHANGE: 20020708 FORMER COMPANY: FORMER CONFORMED NAME: OMNI DOORS INC DATE OF NAME CHANGE: 19971104 8-K 1 form8kacquisition1.htm CURRENT REPORT form8kacquisition1.htm - Generated by SEC Publisher for SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

 
   

Date of Report (Date of earliest event reported):

November 18, 2019

 

 

Kid Castle Educational Corporation

(Exact name of registrant as specified in its charter)

 

Florida

File Number: 333-39629

59-2549529

(State of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

370 Amapola Ave., Suite 200A, Torrance, CA 90501

(Address of principal executive offices) (Zip Code)

 

(310) 895-1839

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

                       

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 

Forward-Looking Statements

 

This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This report and other written and oral statements that we make from time to time contain such forward-looking statements that set out anticipated results based on management’s plans and assumptions regarding future events or performance. We have tried, wherever possible, to identify such statements by using words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will” and similar expressions in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance or results of current and anticipated sales efforts, expenses, the outcome of contingencies, such as legal proceedings, and financial results. Factors that could cause our actual results of operations and financial condition to differ materially are discussed in greater detail under Risk Factors section of this report.

 

We caution that the factors described herein and other factors could cause our actual results of operations and financial condition to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

Item 2.01 - Completion of Acquisition or Disposition of Assets.

Acquisition of CBD Assets from CannabidiolHemp

On November 15, 2019, Kid Castle Educational Corporation, through its wholly owned subsidiary, Cannabinoid Bioscinces, Inc. completed the acquisition of CannabidiolHemp (CannabidiolHemp.net), a premium CBD quality aggregator and standard validator.  This is the beginning of many acquisitions to build Kid Castle into a major “pure-play” CBD operation in the United States and Canada.  Starting with CBD distribution channel, like CannabidiolHemp, Kid Castle is well on its way to become the most vertically integrated “pure-play” CBD operation in the United States and Canada.  Once we have gained a good footing on the CBD distribution channel, we would then move our acquisition machine towards the CBD supply-chain to ensure full vertical integration.  Control of CannabidiolHemp will help Kid Castle in establishing a solid position to lead the standardization of Farm Bill compliant hemp-based medicinal products to serve the rapidly growing CBD market – a segment some analysts have predicted will soar to $11 billion by 2026. 


 

 

Kid Castle Educational Corporation (OTC: KDCE) controls and manages Cannabinoid Biosciences, Inc. (“CBDZ”), a California based Biopharmaceutical Company seeks to revolutionize and standardize the pharmaceuticals and non-pharmaceutical CBD products formulations and applications across the CBD market in the United States of America.    Through Cannabinoid Biosciences, Inc. (CBDZ) Kid Castle plans to push into the legal CBD business that includes: (1) Ownership interest in certain businesses that extract, purchase and distribute Bulk Pure CBD, Isolate, Hemp Oil, THC-free CBD Distillate and Crude CBD Oil; (2) Partnerships with local farmers to grow farm bill compliant hemp biomass; (3) Partnerships with extract facilities across the U.S. who manufacture hemp-based ingredients to meet the specific needs financial products in form of asset-backed loans, business property mortgages and other financial products to qualified individuals/businesses in the legal-CBD businesses.

 

Item 9.01.

Financial Statements and Exhibits.

 

(d)     Exhibits

 

Exhibit No.

 

Description

99.1

 

Press release dated November 18, 2019

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           

 

                                           

                                                                Kid Castle Educational Corporation

 

Dated:

November 18, 2019                 By:

 /s/ Frank I Igwealor

 

 

Frank I Igwealor, CPA, JD, CMA, CFM

 

 

President and CEO

 

EX-99 2 pressreleasecbddistribution.htm NOVEMBER 18, 2019 PRESS RELEASE pressreleasecbddistribution.htm - Generated by SEC Publisher for SEC Filing

KDCE - Kid Castle Acquires CBD Assets CannabidiolHemp

Torrance California, November 15, 2019 (Linkedin page) Kid Castle Educational Corporation (OTC: KDCE) (“Kid Castle” or “the Company”), announces its acquisition of CannabidiolHemp (CannabidiolHemp.net), a premium CBD quality aggregator and standard validator.  This is the beginning of many acquisitions to build Kid Castle into a major “pure-play” CBD operation in the United States and Canada.  Starting with CBD distribution channel, like CannabidiolHemp, Kid Castle is well on its way to become the most vertically integrated “pure-play” CBD operation in the United States and Canada.  Once we have gained a good footing on the CBD distribution channel, we would then move our acquisition machine towards the CBD supply-chain to ensure full vertical integration.  Control of CannabidiolHemp will help Kid Castle in establishing a solid position to lead the standardization of Farm Bill compliant hemp-based medicinal products to serve the rapidly growing CBD market – a segment some analysts have predicted will soar to $11 billion by 2026. 

This acquisition will be accretive to our earnings immediately.  “This acquisition will propel us into a solid position of leadership in CBD product formulation standardization and quality assurance of hemp-based medicinal CBD products,” said Frank Igwealor, Kid Castle’s CEO. “With our vision of building a completely vertically integrated CBD operation model, ensuring quality and premium status of product in our distribution is paramount.“

Motley Fool has predicted U.S. sales of CBD products will more than double every year between 2019 and 2023. Bloomberg has called hemp the “cannabis cash crop” thanks to the booming demand for the non-psychoactive CBD that can be derived from it. CBD is low in THC, the compound that gets users high. Because of its low THC level, hemp-based CBD is finding mainstream acceptance among a public eager for its medicinal value but not wanting the high that comes with other forms of cannabis. 

The CannabidiolHemp acquisition represents the first step in KDCE’s plan to build a fully vertically integrated “pure-play” CBD operation that is an industry leader in the U.S. and Canada. 

About Kid Castle.

Kid Castle Educational Corporation (OTC: KDCE) controls and manages Cannabinoid Biosciences, Inc. (“CBDZ”), a California based Biopharmaceutical Company seeks to revolutionize and standardize the pharmaceuticals and non-pharmaceutical CBD products formulations and applications across the CBD market in the United States of America.    Through Cannabinoid Biosciences, Inc. (CBDZ) Kid Castle plans to push into the legal CBD business that includes: (1) Ownership interest in certain businesses that extract, purchase and distribute Bulk Pure CBD, Isolate, Hemp Oil, THC-free CBD Distillate and Crude CBD Oil; (2) Partnerships with local farmers to grow farm bill compliant hemp biomass; (3) Partnerships with extract facilities across the U.S. who manufacture hemp-based ingredients to meet the specific needs financial products in form of asset-backed loans, business property mortgages and other financial products to qualified individuals/businesses in the legal-CBD businesses.


 

Through CBDZ, Kid Castle intend to established CBD process control, protocols, and formulations standardization.  CBDZ intend to push the Company to step up and pioneer the process to standardize and reorganize this market, establish process control (benchmarks and protocols), and create formulation standards for the CBD industry. Through Kid Castle, CBDZ seeks to control the production and distribution of verities of consumer cannabidiol (CBD) formulation under private brands in the United States. CBDZ’s goal is to bring standardization to the CBD industry, the same way that John D Rockefeller’s Standard Oil brought standardization to crude refining in the United States in the nineteenth century.  Our process standardization would entail steps that include (a) ethanol extraction system, (b) winterization to remove fats; (c) multiple rounds of rotary evaporation are used to remove plant material and other unnecessary components; (d) extract decarboxylation to transform into a crystalline structure with a proprietary post-processing technique; and (e) get the extract tested by third-party laboratories, package it, and get it ready for shipment. For more information, visit the Company’s website at www.cbdxfund.com.  Or our Regulation A+ offering at www.crowdfunder.com/cbdxfund

 

NOTICE REGARDING FORWARD LOOKING STATEMENT 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.